Geistlich Pharma, North America, Inc.

NJ · United States · Reporting entity ID 100000010711

Total reported 2019–2025

$6.64M

#617 of 2,960 reporting companies — 0% of all reported industry payments

$2.40M in general payments across 12,298 records, plus $4.24M in research funding across 127 records.

How it breaks down

General payments $2,398,622

Research funding $4,244,737

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.